Wednesday, August 31, 2016

BRIEF-Genmab: FDA approves Arzerra for treatment of relapsed chronic lymphocytic leukemia

* FDA approved a supplemental biologics license application for use of ofatumumab

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)